一个患有Emery-Dreifuss肌肉衰竭,正在接受心脏再同步治疗的患者的麻醉考虑与心脏起器植入植入
B S M Ng1, E Lim1, K Valchanov1
1Singapore General Hospital Singapore.
Anaesthesia reports
|February 20, 2026
概括
全静脉麻醉是一种安全有效的麻醉技术,用于接受心脏装置植入的Emery-Dreifuss肌肉衰竭患者. 这种方法最大限度地降低了与恶性高温症和心脏不稳定性相关的风险,确保了成功的手术.
科学领域:
- 神经学 神经学
- 心脏病学 心脏病学
- 麻醉学 麻醉学
背景情况:
- 埃梅里-德莱法斯肌肉发育不良 (EDMD) 是一种罕见的遗传神经肌肉疾病.
- EDMD表现为关节收缩,渐进的软弱和心脏并发症,如心肌病和导电缺陷.
- 由于潜在的气道,呼吸道和心脏问题,EDMD患者的麻醉管理是复杂的.
研究的目的:
- 报告一个经过心脏再同步治疗 (CRT) 心脏起器植入的基因确诊的埃默里-德莱法斯肌肉发育不良症患者的成功麻醉管理.
- 突出全静脉麻醉 (TIVA) 在减少EDMD患者麻醉风险方面的有效性.
主要方法:
- 一名27岁的男性确诊EDMD接受了CRT心脏起器植入.
- 通过使用全静脉注射技术诱导和维持麻醉,使用罗库.
- 苏加马德克斯用于神经肌肉阻塞的逆转.
- 恶性高温症的预防措施,为宫运动有限的呼吸道准备,以及减轻心律失常风险是优先考虑的.
主要成果:
- 心脏再同步治疗心脏起器植入程序没有任何事件.
- 患者经历了一次不复杂的康复.
- 静脉内全麻醉被证明是这种EDMD患者的有效麻醉技术.
结论:
- 全静脉麻醉是一种首选和有效的技术,用于管理心脏装置植入的Emery-Dreifuss肌力发育不良症患者的麻醉.
- 精心的手术前评估和特定的麻醉预防措施对于安全管理至关重要.
- 这一案例证明了成功的麻醉管理,降低了拉布地质溶解和恶性热升等反应的风险.
相关概念视频
01:21Skeletal Muscle Relaxants: Adverse Effects
1.2K
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
1.2K
01:31Skeletal Muscle Relaxants: Therapeutic Uses
1.2K
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.2K
01:25Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
01:25Dysrhythmias VII: Nursing Management of Dysrhythmias
508
Nursing management of dysrhythmias involves the following:AssessmentSubjective Assessment:The initial step involves gathering patient-reported symptoms such as dizziness, palpitations, and chest discomfort. It is crucial to collect a detailed history, including previous heart conditions, current medication use, and lifestyle factors like caffeine and alcohol consumption.Objective Assessment:This involves observing clinical signs such as jugular venous distention, cool and pale skin, and...
508
01:25Cardiopulmonary Resuscitation IV: Pharmacological Management
1.6K
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
1.6K
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790